<bill session="116" type="s" number="3200" updated="2020-02-21T05:27:17Z">
  <state datetime="2020-01-15">REFERRED</state>
  <status>
    <introduced datetime="2020-01-15"/>
  </status>
  <introduced datetime="2020-01-15"/>
  <titles>
    <title type="short" as="introduced">Chronic Disease Management Act of 2020</title>
    <title type="short" as="introduced">Chronic Disease Management Act of 2020</title>
    <title type="display">Chronic Disease Management Act of 2020</title>
    <title type="official" as="introduced">A bill to amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible.</title>
  </titles>
  <sponsor bioguide_id="T000250"/>
  <cosponsors>
    <cosponsor bioguide_id="C000174" joined="2020-01-15"/>
    <cosponsor bioguide_id="C001096" joined="2020-01-15"/>
    <cosponsor bioguide_id="M001197" joined="2020-01-15"/>
    <cosponsor bioguide_id="S001191" joined="2020-01-15"/>
    <cosponsor bioguide_id="S001203" joined="2020-01-15"/>
  </cosponsors>
  <actions>
    <action datetime="2020-01-15">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-01-15" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S248" label="text"/>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2020-01-15T05:00:00Z" status="Introduced in Senate">Chronic Disease Management Act of 2020

 This bill modifies requirements for health savings accounts (HSAs) to permit the high deductible health plans required for an HSA to provide care for chronic conditions with no deductible. The bill covers any service or item used to treat a chronic condition if (1) such service or item is low-cost, (2) there is medical evidence of the effectiveness of such service or item, and (3) there is a strong likelihood that the use of such service or item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatment.</summary>
  <committee-reports/>
</bill>
